[query] =>
    [countryCode] => US
    [city] => Ashburn
    [status] => success
    [regionName] => Virginia
    [zip] => 20149
    [as] => AS14618, Inc.
    [country] => United States
    [region] => VA
    [lat] => 39.043800354004
    [lon] => -77.487396240234
    [timezone] => America/New_York
    [isp] => Amazon Technologies Inc.
    [org] => AWS EC2 (us-east-1)

Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
18 May 2020updated 06 Oct 2020 9:45am

Experts raise doubts about Oxford University vaccine after it fails to stop Covid-19 in animal trials

By Samuel Horti

Experts have raised concerns about the effectiveness of the government-backed Oxford University coronavirus vaccine after mixed results in an animal trial.

The vaccine did not stop rhesus macaque monkeys catching the virus in a trial conducted in the US, prompting one academic to call for an “urgent re-appraisal of the ongoing human trials” of the vaccine.

“That viral loads in the noses of vaccinated and unvaccinated animals were identical is very significant,” said Jonathan Ball, professor of molecular virology at the University of Nottingham. “If the same happened in humans, vaccination would not stop spread.”

Dr William Haseltine, a former Harvard Medical School professor who played a central part in early HIV/Aids treatment development, said the results showed “no difference” in viral RNA in vaccinated monkeys versus unvaccinated monkeys. “Which is to say, all vaccinated animals were infected,” he wrote in an article on Forbes.

Eleanor Riley, professor of immunology and infectious diseases at the University of Edinburgh, said: “Whilst the vaccine induced neutralising antibodies and vaccinated animals experienced less severe clinical symptoms than unvaccinated animals (good), the neutralising antibody titres were low and insufficient to prevent infection and – importantly – insufficient to prevent viral shedding in nasal secretions (worrying).”

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. The New Statesman’s weekly environment email on the politics, business and culture of the climate and nature crises - in your inbox every Thursday. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A newsletter showcasing the finest writing from the ideas section and the NS archive, covering political ideas, philosophy, criticism and intellectual history - sent every Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.

If results were similar in humans, the vaccine would only provide partial protection against the disease, and would not prevent its spread, she said.

Content from our partners
How do we secure the hybrid office?
How materials innovation can help achieve net zero and level-up the UK
Fantastic mental well-being strategies and where to find them

New Statesman political correspondent Ailbhe Rea has written today about why the government’s gamble on the Oxford University vaccine is a necessary one. You can read the full piece here.